Vector Bioscience Cambridge
PrivateLast Round
Series A
May 21, 2025
Total Funding Raised
$3.26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vector Bioscience Cambridge operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in March 2023.
Vector Bioscience Cambridge is a biotechnology company developing a machine-learning empowered drug delivery platform using nanoshuttle technology for the targeted release of therapeutics in oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vector Bioscience Cambridge Comparables
Compare Vector Bioscience Cambridge with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NaDeNo Nanoscience | 79% | |
| Optimeos Life Sciences | 77% | |
| Hone Bio | 77% |
For institutional investors. Book with your work email.
Vector Bioscience Cambridge Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 21, 2025 | ||||
| Grant | Mar 1, 2023 | ||||
| Accelerator | Jun 16, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vector Bioscience Cambridge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Innovate UK | Grant |
| Cambridge Enterprise | Accelerator, Grant |
| Endless Frontier Labs | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 107% MoM, reaching 1.9K.
- Jan 14, 2025
Monthly visitors grew 40% MoM.
For institutional investors. Book with your work email.
Vector Bioscience Cambridge Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vector Bioscience Cambridge's valuation, stock price, and market status.
Is Vector Bioscience Cambridge a public or private company?
Vector Bioscience Cambridge is a private company.
What is the current stock price of Vector Bioscience Cambridge?
Vector Bioscience Cambridge is a private company, so its shares have no public market price. Caplight tracks Vector Bioscience Cambridge's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vector Bioscience Cambridge worth (valuation)?
Valuation information for Vector Bioscience Cambridge is not publicly available.
Can I buy Vector Bioscience Cambridge stock?
Vector Bioscience Cambridge shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vector Bioscience Cambridge's last funding round?
Vector Bioscience Cambridge's most recent funding round was Series A on May 21, 2025.
Who are the main investors in Vector Bioscience Cambridge?
Key investors in Vector Bioscience Cambridge include European Innovation Council Fund, Innovate UK, Cambridge Enterprise, Endless Frontier Labs.
Will Vector Bioscience Cambridge IPO soon?
No public IPO plans have been announced for Vector Bioscience Cambridge.
How can I track Vector Bioscience Cambridge secondary market activity?
Caplight tracks bids, offers, and trades in Vector Bioscience Cambridge's shares on secondary markets.